Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results
Appointed director

LifeStance Health Group, Inc. Create: Alert

All | News | Filings
Date FiledTypeDescription
10/02/2023 144 Form 144 - Report of proposed sale of securities:
08/09/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/08/2023 8-K Quarterly results
Docs: "LifeStance Reports Second Quarter 2023 Results",
"Q2 Q1 Q4 Q3 Q2 Q1"
07/20/2023 144 Form 144 - Report of proposed sale of securities:
07/03/2023 144 Form 144 - Report of proposed sale of securities:
06/12/2023 144 Form 144 - Report of proposed sale of securities:
06/02/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
05/10/2023 10-Q Quarterly Report for the period ended March 31, 2023
04/21/2023 ARS Form ARS - Annual Report to Security Holders:
04/21/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/21/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
03/09/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
03/09/2023 10-K Annual Report for the period ended December 31, 2022
02/13/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/09/2023 SC 13G/A FMR LLC reports a 7.7% stake in LIFESTANCE HEALTH GROUP INC
11/09/2022 10-Q Quarterly Report for the period ended September 30, 2022
11/08/2022 8-K Quarterly results
Docs: "LifeStance Reports Third Quarter 2022 Results",
"Q3 Q2 Q1 Q4 Q3 Q2 Q1"
11/03/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "LIFESTANCE HEALTH APPOINTS J. MICHAEL BRUFF AS NEW BUSINESS TRANFORMATION OFFICER; DAVID BOURDON AS CHIEF FINANCIAL OFFICER"
09/08/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "LifeStance Health Appoints Ken Burdick as CEO and Chairman; Founding CEO and Chairman Michael Lester Retires"
06/02/2022 8-K Quarterly results
05/24/2022 8-K Quarterly results
05/23/2022 8-K Quarterly results
05/11/2022 10-Q Quarterly Report for the period ended March 31, 2022
05/09/2022 8-K Quarterly results
04/21/2022 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/21/2022 DEF 14A Form DEF 14A - Other definitive proxy statements:
04/11/2022 SC 13G/A FMR LLC reports a 10.3% stake in LIFESTANCE HEALTH GROUP INC
03/17/2022 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
03/17/2022 10-K Annual Report for the period ended December 31, 2021
03/10/2022 8-K Quarterly results
02/18/2022 SC 13G Lester Michael K. has filed a Schedule 13D for LifeStance Health Group, Inc.
02/14/2022 SC 13G Silversmith Partners I GP, LLC reports a 5.2% stake in LifeStance Health Group, Inc.
02/11/2022 SC 13G TPG GP A, LLC reports a 46.8% stake in LifeStance Health Group, Inc.
02/09/2022 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy